Suchergebnisse - "O'Day, Steven J"

PubPharm (117)

41

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

enthalten in: The New England journal of medicine | 2011

von Chapman, P. | Hauschild, A. | Robert, C. | +25

42

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

enthalten in: Investigational new drugs | 2011

von Hersh, E. | O'Day, S. | Powderly, J. | +7

43

Current and future adjuvant immunotherapies for melanoma : blockade of cytotoxic T-lymphocyte antigen-4 as a novel approach

enthalten in: Cancer treatment reviews | 2011

von Agarwala, S. | O'Day, S.

44

Current and future adjuvant immunotherapies for melanoma: Blockade of cytotoxic T-lymphocyte antigen-4 as a novel approach

enthalten in: Cancer treatment reviews | 2011

von Agarwala, S. | O’Day, S.

45

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2011

von O’Day, S. | Pavlick, A. | Albertini, M. | +7

46

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2011

von O’Day, S. | Pavlick, A. | Albertini, M. | +7

47

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2011

von O’Day, S. | Pavlick, A. | Albertini, M. | +7

48

Ipilimumab efficacy and safety in patients with advanced melanoma : a retrospective analysis of HLA subtype from four trials

enthalten in: Cancer immunity | 2010

von Wolchok, J. | Weber, J. | Hamid, O. | +9

CommentIn: Immunotherapy. 2011 May;3(5):595-9. - PMID 21554088

49

Improved survival with ipilimumab in patients with metastatic melanoma

enthalten in: The New England journal of medicine | 2010

von Hodi, F. | O'Day, S. | McDermott, D. | +26

ErratumIn: N Engl J Med. 2010 Sep 23;363(13):1290

50

Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Koyanagi, K. | O'Day, S. | Boasberg, P. | +12